Loading clinical trials...
Loading clinical trials...
A Phase 1, Dose Escalation, and Pharmacokinetic Study of ProMetic Plasminogen Administered as Intravenous Infusion in Adults and Children With Hypoplasminogenemia
Conditions
Interventions
Plasminogen (Human) Intravenous
Locations
1
United States
Indiana Hemophilia and Thrombosis Center
Indianapolis, Indiana, United States
Start Date
December 1, 2014
Primary Completion Date
December 1, 2015
Completion Date
February 1, 2016
Last Updated
August 29, 2017
Lead Sponsor
Prometic Biotherapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions